GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.
The Scientist
Most Recent
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
A public-private partnership including 13 pharmaceutical companies pledge more than $785 million to fight neglected tropical diseases.
The agency releases draft guidelines on unsolicited questions about off-label use, but leaves many questions about social media marketing unanswered.
Some Big Pharma companies are turning to the world’s automobile makers for advice on innovation and profitability.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
